Related Articles
Identification of the TP53-induced glycolysis and apoptosis regulator in various stages of colorectal cancer patients
Differential expression of mucins in Middle Eastern patients with colorectal cancer
Blocking the Wnt/β‑catenin signaling pathway to treat colorectal cancer: Strategies to improve current therapies (Review)
Induction of ROS‑mediated cell death and activation of the JNK pathway by a sulfonamide derivative
GSK-3β inhibitor 6-bromo-indirubin-3'-oxime promotes both adhesive activity and drug resistance in colorectal cancer cells